10-QPeriod: Q3 FY2007

DEXCOM INC Quarterly Report for Q3 Ended Sep 30, 2007

Filed October 30, 2007For Securities:DXCM

Summary

DexCom, Inc. (DXCM) filed its quarterly report for the period ending September 30, 2007. As an "accelerated filer" but not a "large accelerated filer" or "shell company," the company is in a growth phase. The filing includes unaudited financial statements for the balance sheet, statements of operations, and cash flows, along with detailed notes and management's discussion and analysis. Investors should note that this report covers a period prior to significant market events and company growth. The core of the filing will be the detailed financial performance and the company's outlook as presented by management. Key areas to scrutinize will be revenue trends, profitability, cash burn, and any disclosed risks that could impact future performance.

Key Highlights

  • 1The report is a Form 10-Q for the quarterly period ended September 30, 2007.
  • 2DexCom, Inc. is incorporated in Delaware and its principal executive offices are located in San Diego, California.
  • 3The company is classified as an "accelerated filer" but not a "large accelerated filer" or "shell company."
  • 4As of October 16, 2007, there were 28,295,788 shares of common stock outstanding.
  • 5The filing includes unaudited financial statements: Balance Sheets, Statements of Operations, and Statements of Cash Flows.
  • 6Management's Discussion and Analysis of Financial Condition and Results of Operations is a key section for understanding performance.
  • 7The report also covers other information, including Legal Proceedings, Risk Factors, and Exhibits.

Frequently Asked Questions

This Form 10-Q filing provides an update on DexCom, Inc.'s financial performance and condition for the quarterly period ended September 30, 2007. It includes unaudited financial statements, management's analysis of the results, and other relevant business information.

This filing contains the financial statements and management's discussion, which would detail revenue, expenses, assets, liabilities, and cash flows for the period. Investors would need to review these specific financial statements and the MD&A section for a comprehensive understanding of the company's financial health at that time.

The "Risk Factors" section (Item 1A) in Part II of the Form 10-Q would outline the specific risks and uncertainties that could affect DexCom's business, financial condition, and results of operations. These could range from market competition and regulatory challenges to product development and manufacturing issues.

Being an "accelerated filer" indicates that DexCom meets certain size and filing history requirements, typically having a public float of $75 million or more. This status suggests the company is of a certain scale but may not yet be as large as a "large accelerated filer." It implies a more established company than a "non-accelerated filer" but still potentially in a significant growth or development stage.